Medicines and Healthcare products Regulatory Agency: Redundancy

Department of Health and Social Care written question – answered on 1st October 2021.

Alert me about debates like this

Photo of Grahame Morris Grahame Morris Labour, Easington

To ask the Secretary of State for Health and Social Care, what discussions he has had with executive officers at the Medicines and Healthcare products Regulatory Agency regarding the proposed redundancies at that agency.

Photo of Grahame Morris Grahame Morris Labour, Easington

To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of staffing levels at the Medicines and Healthcare products Regulatory Agency to carry out its day-to-day functions.

Photo of Grahame Morris Grahame Morris Labour, Easington

To ask the Secretary of State for Health and Social Care, what discussions his Department has had with staff representatives at the Medicines and Healthcare products Regulatory Agency on proposed redundancies at that agency; and if he will undertake an equality impact assessment relating to those proposed redundancies.

Photo of Edward Argar Edward Argar Minister of State (Department of Health and Social Care)

Ministers and officials meet regularly with the Medicines and Healthcare products Regulatory Agency (MHRA) to discuss a range of issues, including its transformation plans to become a more dynamic and efficient organisation. The Department has not made a specific assessment of the MHRA’s staffing levels.

The MHRA is carrying out a series of equality and diversity impact assessments throughout the transformation continues to engage with trade unions and employees through a formal consultation as well as continuing opportunities for engagement with senior leaders.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.